<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-ijerph-17-00440">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grishchenko</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grieve</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Sweeting</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>De Angelis</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Thomson</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Ryder</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Irving</surname>
    <given-names>W.L.</given-names>
   </name>
  </person-group>
  <article-title>Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice</article-title>
  <source>Int. J. Technol. Assess. Health Care</source>
  <year>2009</year>
  <volume>25</volume>
  <fpage>171</fpage>
  <lpage>180</lpage>
  <pub-id pub-id-type="doi">10.1017/S0266462309090229</pub-id>
  <pub-id pub-id-type="pmid">19331708</pub-id>
 </element-citation>
</ref>
